Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akua A Frimpong

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|May 7, 2021
Medication Use Among Patients With COVID-19 in a Large, National Dataset: Cerner Real-World Data™Stephanie J Stroever, Daniel Ostapenko, Robyn Scatena, et al.
Ophthalmology|February 19, 2026
The Impact of the Rabb-Venable Program on the Ophthalmology WorkforceAkua A Frimpong, Dolly-Ann Padovani-Claudio, Mildred M G Olivier, et al.
Ophthalmology Science|September 2, 2025
Proliferative Diabetic Retinopathy Disproportionately Impacts Distressed Communities Near a Northeastern Academic CenterAkua A Frimpong, Thomas L Chang, June-Marie Weiss, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|May 7, 2021
Medication Use Among Patients With COVID-19 in a Large, National Dataset: Cerner Real-World Data™Stephanie J Stroever, Daniel Ostapenko, Robyn Scatena, et al.
Ophthalmology|February 19, 2026
The Impact of the Rabb-Venable Program on the Ophthalmology WorkforceAkua A Frimpong, Dolly-Ann Padovani-Claudio, Mildred M G Olivier, et al.
Ophthalmology Science|September 2, 2025
Proliferative Diabetic Retinopathy Disproportionately Impacts Distressed Communities Near a Northeastern Academic CenterAkua A Frimpong, Thomas L Chang, June-Marie Weiss, et al.
Pageof 1